Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
A year ago it was even less time. What does that mean?
You mean divisor/dividend/quotient, right???????
Big if...just lurking...
I know...I SAID WE ARE DONE! We are.
Thank you Capt. Obvious. This stock is done. Let's take our loss and go home. What more can be done? I'm out.
Question from a long faded away long who's still alive...I will not reveal my source. ;) Here goes: "What's going on with Cotara Phase 3? Is the discussion all based on the Indian publication, or did PPHM also say something about Phase 3."
Wow, I actually agree with you. ;)
To me it's always 16. I know the splits and all that.
Gotcha but, to me, it's always gonna be 16.
Was never that high. 16 intra-day high.
PH.II data through the years: http://ir.peregrineinc.com/releasedetail.cfm?releaseid=579150 http://ir.peregrineinc.com/releasedetail.cfm?releaseid=519513 http://www.onemedplace.com/blog/archives/3265 http://www.drugs.com/clinical_trials/peregrine-pharmaceuticals-presents-promising-phase-data-asco-provides-clinical-update-phase-ii-4592.html http://www.emaxhealth.com/39/14736.html http://sci.rutgers.edu/forum/showthread.php?t=59284 http://www.prnewswire.com/news-releases/newly-published-data-shows-potential-of-peregrines-tarvacintm-to-treat-primary-and-metastatic-pancreatic-cancer-53406417.html
http://files.shareholder.com/downloads/PPHM/1513709056x0x133866/1e511be4-408e-416e-ad4c-3406378bdd58/PPHM_News_2004_10_22_General.pdf
All promising, all good. Same song through the years. What happened????
Geo, I love ya but you're chasing rainbows. Right now, there is nothing to see or talk about with this stock. PPS is terrible and it can only go up. PHIII is the pot of gold...means we are serious about getting to market. Until then, fuggetta aboudit.
Bill Gross finds flaw in world economy. News? http://finance.yahoo.com/blogs/daily-ticker/shades-greenspan-bond-king-bill-gross-finds-huge-154044318.html Love how Henry Blodgett is in this video. He was a "crook" at Merrill.
What was the important news?
Exactly...
I know. How's that for a website? I don't have much confidence in that one.
From ChinaAnalyst.com: "Peregrine Pharmaceuticals (NASDAQ:PPHM) has the 2nd highest upside potential in this segment of the market. Its upside is 612.5%. Its consensus target price is $7.13 based on the average of all estimates." Is that comforting or what???
Finally a PH.III???....2.) Cotara® Phase III Planning: Peregrine reported strong interim overall median survival of 8.8 months (38 weeks) for its Phase II trial of Cotara® for the treatment of recurrent glioblastoma multiforme (brain cancer). This compares favorably to the typical patient prognosis of approximately 6 months at first relapse. Peregine plans to meet with the FDA to discuss the most appropriate Phase III trial plans in Q4 which might be conducted under a Special Protocol Assessment (SPA).
Another "break out" article for PPHM. http://www.thestreet.com/_yahoo/story/11301969/1/5-stocks-poised-for-breakouts.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA
We must be getting ready for another Rodman/Renshaw Conference presentation. WooHooo
Pretty sad, isn't it?
No reaction? No one pissed they got raises?
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=68232733
Based on the “Factors for Determining Compensation”, as noted below, the annual base salary and percentage increase in base salary of our Named Executive Officers as of May 1, 2011 (beginning of fiscal year 2012) was as follows:
Named Executive Officer
Percentage Increase from Fiscal Year 2011 (%)
Steven W. King
$429,000 10%
Paul J. Lytle
$325,812 7%
Shelley P.M. Fussey, Ph.D
$280,500 2%
Joseph S. Shan
$260,000 4%
Our PPS is down almost 75% and the boys get a pay raise.
May 3, 2010 $4.12
I'm sure it will be a swanky affair! Nothing but the best paper plates and cups for everyone.
HAven't we been at the Hep thing for a long time now? Why is it taking so long to get results from that? Isn't it much easier to see results for Hep C than say cancer trials?
Pre-market! Pre-market! What's happening?!?!?!?! We're trading!!!! Something's up. Oops, got a bit carried away. ;)
Flying, aren't we??? Have a good weekend.
What sarcasm?
It means what it said. I've heard the same old refrain of wait a couple of months or after this or that enrollment we soar. It gets old. BUT, you are entitled to your opinion.
Oh say whatever you want. There's always the next month or year or years...When does it end?
From Yahoo board: "Avid is in talks and has a contract pending with IBIO to produce Bavi on the IBIO launch platform." ???
Yeah, not a great word or word choice. Unfortunately treatment with docetaxel alone is expected to result in less than a 6%(1) tumor response rate, but since docetaxel increases exposure of bavituximab's PS target, we believe the combination has a good chance to improve on these results and hopefully improve overall survival for patients who have already failed a prior treatment for this deadly form of cancer. SHOULD just take out Unfortunately and read as is.
Under 20 cents...have we ever been that low???? oy
When does the bloodletting end? A 20 cent stock...never thought it would be.
Have we treated or not? http://www.siliconinvestor.com/readmsg.aspx?msgid=27661208
23 cents a share...is that a new low????
Why present. What has it ever gotten us?
WHY???
Any pre-market activity??? Really making a lot of noise, huh?